Polycystic ovary syndrome (PCOS) has no single cause. It develops from a combination of genetic predisposition, hormonal imbalances, metabolic dysfunction, and environmental factors that reinforce each other in a self-perpetuating cycle. PCOS affects an estimated 10 to 13% of women of reproductive age worldwide, according to the World Health Organization, and up to 70% of those cases go undiagnosed. Understanding what drives the condition helps explain why it looks different from person to person and why it affects so much more than the ovaries.
Genetics Set the Foundation
Twin studies estimate the heritability of PCOS at roughly 70%, meaning genetics account for the majority of a person’s susceptibility. No single “PCOS gene” has been identified. Instead, dozens of gene variants contribute small amounts of risk, and they cluster around two key functions: androgen production and insulin signaling.
On the androgen side, genes like CYP17 (involved in making male hormones) and the androgen receptor gene influence how much testosterone the ovaries produce and how sensitive the body is to it. On the metabolic side, genes tied to the insulin receptor, insulin signaling pathways, and fat cell regulation affect how efficiently the body processes blood sugar. When someone inherits a combination of risk variants from both categories, the conditions for PCOS are in place long before symptoms appear.
Insulin Resistance Fuels Excess Androgens
Insulin resistance is one of the most important drivers of PCOS. When cells stop responding normally to insulin, the pancreas compensates by pumping out more of it. That extra circulating insulin doesn’t just affect blood sugar. It acts directly on the ovaries, stimulating specialized cells called theca cells to ramp up production of testosterone and other androgens. Research confirms that insulin resistance within theca cells can directly exaggerate androgen output, independent of what’s happening elsewhere in the body.
This creates a feedback loop: higher insulin drives higher androgens, and higher androgens promote fat storage around the midsection, which worsens insulin resistance. The metabolic consequences are significant. More than half of women with PCOS develop type 2 diabetes by age 40, according to the CDC. Insulin resistance is present in the majority of women with PCOS, including those at a normal weight, which is why lean women can still develop the full syndrome.
A Hormonal Signaling Problem in the Brain
PCOS also involves a disruption in the brain’s reproductive control center. Normally, a region of the brain releases a hormone called GnRH in carefully timed pulses that alternate between stimulating two pituitary hormones: LH (luteinizing hormone) and FSH (follicle-stimulating hormone). In women with PCOS, GnRH pulses fire too fast, and they don’t slow down properly in response to estrogen and progesterone the way they should.
The result is an elevated LH-to-FSH ratio. Too much LH pushes the ovaries to produce more androgens. Too little FSH means follicles can’t mature fully, so they stall partway through development and accumulate as the small cysts visible on ultrasound. Without a dominant follicle completing its growth, ovulation becomes irregular or stops altogether. This is why PCOS is one of the leading causes of difficulty getting pregnant.
Chronic Low-Grade Inflammation
Women with PCOS consistently show markers of chronic, low-level inflammation throughout the body. C-reactive protein, a blood marker of inflammation, is significantly higher in women with PCOS regardless of whether they are lean or overweight. White blood cell counts are also elevated and correlate directly with testosterone levels and free androgen levels.
This inflammatory state appears to independently stimulate androgen production by the ovaries while also worsening insulin resistance. Excess body fat, particularly visceral fat around the organs, produces inflammatory signaling molecules that feed into the same cycle. But inflammation is present even in normal-weight women with PCOS, suggesting it’s an intrinsic feature of the condition rather than simply a consequence of carrying extra weight.
Programming That Begins Before Birth
Some of the groundwork for PCOS may be laid in the womb. Research in animal models has shown that when female fetuses are exposed to higher-than-normal levels of androgens during development, they go on to develop PCOS-like features in adulthood: irregular cycles, elevated testosterone, excess LH, disrupted fat distribution, and impaired insulin signaling.
Studies in rhesus monkeys found that female offspring exposed to male-level testosterone in utero developed both the reproductive and metabolic hallmarks of PCOS as adults. In sheep, prenatal androgen exposure reduced the sensitivity of the brain’s GnRH system to normal hormonal feedback, leading to the same kind of persistently fast GnRH pulsing seen in human PCOS. Mouse studies have shown that prenatal androgens can reprogram brain circuits involved in GnRH regulation, altering them permanently.
The implication is that some women may enter life with a nervous system and ovarian environment already primed for PCOS, with puberty and weight gain acting as triggers that activate a predisposition set years earlier. Researchers have proposed that common genetic variants affecting androgen levels during fetal development could provide the link between the genetic and developmental origins of the syndrome.
Gut Bacteria and Metabolic Disruption
The composition of gut bacteria differs measurably between women with PCOS and those without. Women with PCOS tend to have lower bacterial diversity overall and a higher abundance of a bacterial group called Bacteroidetes. These bacteria break down certain bile acids that normally activate a receptor in the intestinal lining involved in regulating blood sugar.
When researchers at Peking University removed gut bacteria in PCOS mouse models, insulin resistance improved and PCOS features diminished. The proposed pathway works like this: an overgrowth of Bacteroidetes breaks down too much of a specific bile acid, which reduces activation of a metabolic receptor in the gut wall, which in turn disrupts glucose metabolism. Restoring activation of that receptor improved metabolic function in the mice. This line of evidence suggests that the gut microbiome isn’t just a bystander in PCOS but actively contributes to the insulin resistance that drives the condition.
Environmental Chemicals That Mimic Hormones
Certain synthetic chemicals in everyday products can interfere with the hormonal systems involved in PCOS. Bisphenol A (BPA), found in plastics and food container linings, is one of the most studied. BPA can disrupt glucose regulation, promote excess insulin production, and even trigger epigenetic changes, modifications to how genes are read without altering the DNA itself. In animal models, BPA exposure increases insulin secretion, a change that could push the same androgen-producing cascade seen in insulin-resistant PCOS.
Triclosan, an antibacterial agent previously common in soaps and toothpaste, has shown estrogenic, antiestrogenic, and antiandrogenic activity in lab studies, all of which can contribute to hormonal disruption resembling PCOS. In zebrafish, triclosan caused oxidative damage to ovarian tissue. While the human data is still correlational, the sheer volume of hormone-disrupting chemicals in the modern environment represents a plausible contributor, particularly for women who already carry genetic susceptibility.
How These Causes Reinforce Each Other
What makes PCOS so persistent is that its causes don’t operate in isolation. Genetic susceptibility may determine which pathways are vulnerable, but insulin resistance, inflammation, and hormonal dysregulation form interlocking feedback loops. Excess insulin drives androgen production. Excess androgens promote abdominal fat storage. Abdominal fat generates inflammatory signals. Inflammation worsens insulin resistance. And the brain’s GnRH system, potentially primed by prenatal androgen exposure, keeps LH elevated and ovulation suppressed.
This is why PCOS is diagnosed based on a pattern rather than a single test. The current international guidelines, updated in 2023, require at least two of three features: signs of excess androgens (acne, excess hair growth, or elevated testosterone on bloodwork), irregular or absent ovulation, and polycystic-appearing ovaries on ultrasound or elevated anti-Müllerian hormone levels. Other conditions that mimic these symptoms, such as thyroid disorders or adrenal hyperplasia, need to be ruled out first.
Because so many systems are involved, treatments that address just one pathway often produce only partial improvement. The most effective approaches tend to target multiple drivers at once, particularly insulin resistance through lifestyle changes and, when needed, medication, while managing specific symptoms like excess hair growth or irregular periods individually.